Identification of a predictive metabolic signature of response to immune checkpoint inhibitors in non-small cell lung cancer: METABO-ICI clinical study protocol.
- DOI
- 10.1016/j.resmer.2021.100845
- Published
- 2021 Nov
- Container
- Respiratory medicine and research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.resmer.2021.100845,
title = {Identification of a predictive metabolic signature of response to immune checkpoint inhibitors in non-small cell lung cancer: METABO-ICI clinical study protocol.},
author = {Sannicolo S and Giaj Levra M and Le Gouellec A and Aspord C and Boccard J and Chaperot L and Toussaint B and Moro-Sibilot D and Hannani D and Toffart AC},
year = {2021},
journal = {Respiratory medicine and research},
doi = {10.1016/j.resmer.2021.100845},
url = {https://doi.org/10.1016/j.resmer.2021.100845}
}RIS
TY - JOUR TI - Identification of a predictive metabolic signature of response to immune checkpoint inhibitors in non-small cell lung cancer: METABO-ICI clinical study protocol. AU - Sannicolo S AU - Giaj Levra M AU - Le Gouellec A AU - Aspord C AU - Boccard J AU - Chaperot L AU - Toussaint B AU - Moro-Sibilot D AU - Hannani D AU - Toffart AC PY - 2021 JO - Respiratory medicine and research DO - 10.1016/j.resmer.2021.100845 UR - https://doi.org/10.1016/j.resmer.2021.100845 ER -
APA
S, S., M, G. L., A, L. G., C, A., J, B., L, C., B, T., D, M., D, H., & AC, T. (2021). Identification of a predictive metabolic signature of response to immune checkpoint inhibitors in non-small cell lung cancer: METABO-ICI clinical study protocol.. Respiratory medicine and research. https://doi.org/10.1016/j.resmer.2021.100845
Source records
- pubmed · retrieved 2026-09-27T01:34:19.951Z